FDA expands use of rivaroxaban to treat, reduce recurrence of DVT, PE
November 5th 2012FDA has expanded the approved use of oral anticoagulant rivaroxaban (Xarelto, Janssen) to include three new indications: treatment of deep vein thrombosis (DVT), treatment of pulmonary embolism (PE), and reducing the risk of recurrent DVT and PE following initial treatment.
Web-based self-management program improves blood pressure control
November 5th 2012An automated online self-management program may help employees with prehypertension or hypertension achieve adequate blood pressure control, according to a study published in the October issue of American Heart Journal.
Similar bleeding rates seen with two anticoagulants
November 2nd 2012Bleeding rates associated with new use of dabigatran (Pradaxa, Boehringer Ingelheim) do not appear to be higher than bleeding rates associated with new use of warfarin, according to an FDA safety review of post-market reports of serious bleeding events.
Balancing good customer service with good patient health care
November 1st 2012The United States may be the world's last bastion of customer service. Inherent in our national psyche is the expectation that when we pull out our wallets to purchase something, whether a product or a service, we have a right to satisfaction.
Mass. DPH shuts down another compounding facility, plans to hire more inspectors
November 1st 2012The Massachusetts Department of Health (DPH) announced Oct. 28 at a press conference that it will be adding five more inspectors to the Board of Pharmacy to continue its investigation of the New England Compounding Center, the Ameridose pharmacy, and other unannounced inspections at compounding pharmacies that prepare sterile injectables.
FDA Confirms Fungus Associated with Meningitis Outbreak
November 1st 2012FDA and the CDC confirm that the fungus Exserohilium rostratum contaminated one of the three implicated lots of preservative-free methylprednisone acetate (80 mg/mL) from the New England Compounding Center which the company recalled September 26.